FDA-approved heterocyclic molecules for cancer treatment: Synthesis, dosage, mechanism of action and their adverse effect
Open Access
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Identification and optimization of pyridazinones as potent and selective c-Met kinase inhibitorsBioorganic & Medicinal Chemistry Letters, 2015
- Design, Synthesis, and Pharmacological Evaluation of Fluorinated Tetrahydrouridine Derivatives as Inhibitors of Cytidine DeaminaseJournal of Medicinal Chemistry, 2014
- Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluationBioorganic & Medicinal Chemistry Letters, 2013
- Raise standards for preclinical cancer researchNature, 2012
- Discovery of 1-{4-[1-(2,6-Difluorobenzyl)-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea (TAK-385) as a Potent, Orally Active, Non-Peptide Antagonist of the Human Gonadotropin-Releasing Hormone ReceptorJournal of Medicinal Chemistry, 2011
- One Step Radiosynthesis of 6-[18F]Fluoronicotinic Acid 2,3,5,6-Tetrafluorophenyl Ester ([18F]F-Py-TFP): A New Prosthetic Group for Efficient Labeling of Biomolecules with Fluorine-18Journal of Medicinal Chemistry, 2010
- A new approach to the synthesis of l-3-hydroxy-4-methoxy-5-methyl-phenylalanine derivatives from l-tyrosineTetrahedron: Asymmetry, 2010
- Synthesis and biological evaluation of new heterocyclic quinolinones as anti-parasite and anti-HIV drug candidatesBioorganic & Medicinal Chemistry Letters, 2009
- Enantioselective Total Synthesis of Ecteinascidin 743Journal of the American Chemical Society, 1996
- C2 symmetry and asymmetric inductionChemical Reviews, 1989